{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:52:17Z","timestamp":1778777537313,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1053\/j.jrn.2025.07.004","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:09:36Z","timestamp":1752793776000},"page":"578-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation and Management of Obesity in Chronic Kidney Disease"],"prefix":"10.1053","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2515-1748","authenticated-orcid":false,"given":"Allon N.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2025.07.004_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.jrn.2025.07.004_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2025.07.004_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2025.07.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100568","article-title":"Prevalence of obesity and CKD among adults in the United States, 2017-2020","volume":"5","author":"Friedman","year":"2023","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000453","article-title":"Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries","volume":"2","author":"Anand","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1053\/j.jrn.2025.07.004_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193559","article-title":"Obesity and chronic kidney disease: a population-based study among South Koreans","volume":"13","author":"Evangelista","year":"2018","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2025.07.004_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the Sixth China chronic disease and risk factor Surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Int Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ndt\/gfu383","article-title":"Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey","volume":"30","author":"De Nicola","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2025.07.004_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s42255-024-01106-8","article-title":"On the pathogenesis of obesity: causal models and missing pieces of the puzzle","volume":"6","author":"Magkos","year":"2024","journal-title":"Nat Metab"},{"key":"10.1053\/j.jrn.2025.07.004_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s42255-023-00782-2","article-title":"Total daily energy expenditure has declined over the past three decades due to declining basal expenditure, not reduced activity expenditure","volume":"5","author":"Speakman","year":"2023","journal-title":"Nat Metab"},{"key":"10.1053\/j.jrn.2025.07.004_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/oby.22071","article-title":"Complementary Hypotheses on contributors to the obesity Epidemic","volume":"26","author":"Davis","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2025.07.004_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.kint.2023.10.014","article-title":"Anti-obesity pharmacotherapy in adults with chronic kidney disease","volume":"105","author":"Taber-Hight","year":"2024","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"American Heart, A: a Synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific Statement from the American Heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2025.07.004_bib15","article-title":"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","volume":"364","author":"Chang","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2025.07.004_bib16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","article-title":"A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population","volume":"91","author":"Garofalo","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/2013.jamainternmed.85","article-title":"Body mass index in 1.2 million adolescents and risk for end-stage renal disease","volume":"172","author":"Vivante","year":"2012","journal-title":"Arch Int Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.100982","article-title":"Body mass index in late adolescence and later life kidney outcomes: a population-based cohort study in Swedish men","volume":"7","author":"Vitkauskaite","year":"2025","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13656","article-title":"Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: a systematic review and meta-analysis","volume":"25","author":"Iqbal","year":"2024","journal-title":"Obes Rev"},{"key":"10.1053\/j.jrn.2025.07.004_bib20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.kint.2018.12.019","article-title":"Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding","volume":"95","author":"Xu","year":"2019","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/clinem\/dgac057","article-title":"Body mass index and risk of diabetic nephropathy: a mendelian randomization study","volume":"107","author":"Lu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2025.07.004_bib22","article-title":"Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation","volume":"11","author":"Martin","year":"2022","journal-title":"Elife"},{"key":"10.1053\/j.jrn.2025.07.004_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2020050679","article-title":"Conventional and genetic evidence on the association between adiposity and CKD","volume":"32","author":"Zhu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ckj\/sfx022","article-title":"Obesity and listing for renal transplantation: weighing the evidence for a growing problem","volume":"10","author":"Hossain","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.jrn.2025.07.004_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.avsg.2023.02.005","article-title":"The effect of obesity on outcomes after arteriovenous Fistulae creation: a systematic review","volume":"92","author":"Lee","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.ajkd.2017.09.010","article-title":"Impact of obesity on modality Longevity, Residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients","volume":"71","author":"Obi","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2025.07.004_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 Years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ekir.2017.01.009","article-title":"The obesity paradox in kidney disease: how to Reconcile it with obesity management","volume":"2","author":"Kalantar-Zadeh","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2025.07.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0059-5","article-title":"The obesity paradox in chronic disease: facts and numbers","volume":"3","author":"Lainscak","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Suppl 4","key":"10.1053\/j.jrn.2025.07.004_bib30","doi-asserted-by":"crossref","first-page":"iv65","DOI":"10.1093\/ndt\/gft242","article-title":"Obesity as an effect modifier of the risk of death in chronic kidney disease","volume":"28","author":"Kramer","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2025.07.004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100804","article-title":"Measuring albuminuria in individuals with obesity: Pitfalls of the urinary albumin-creatinine ratio","volume":"6","author":"Chagnac","year":"2024","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib32","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2025.07.004_bib33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41366-019-0476-z","article-title":"The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors","volume":"44","author":"Lopez-Martinez","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.jrn.2025.07.004_bib34","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000797","article-title":"Measurement, estimation, and correlates of the glomerular filtration rate before and after bariatric surgery","author":"Friedman","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000357231","article-title":"Predicting the glomerular filtration rate in bariatric surgery patients","volume":"39","author":"Friedman","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semnephrol.2021.06.007","article-title":"Obesity-related glomerulopathy: clinical management","volume":"41","author":"Herman-Edelstein","year":"2021","journal-title":"Sem Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib37","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000760","article-title":"Obesity, underweight, and Accuracy of eGFR using cystatin C and creatinine in a Northern European population","author":"Russel","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib38","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfh983","article-title":"Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example","volume":"20","author":"Delanaye","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2025.07.004_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.jrn.2017.03.004","article-title":"Personal attitudes toward weight in overweight and obese US Hemodialysis patients","volume":"27","author":"Saeed","year":"2017","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2025.07.004_bib41","first-page":"1","article-title":"Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006","author":"Navaneethan","year":"2012","journal-title":"Int J Obes"},{"key":"10.1053\/j.jrn.2025.07.004_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.ajkd.2023.02.005","article-title":"Patient and health care professional Perspectives on addressing obesity in ESKD","volume":"82","author":"Harhay","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2025.07.004_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/20543581221129465","article-title":"Recognition of obesity and perceptions of weight loss management in patients with chronic kidney disease: a retrospective Cross-Sectional study","volume":"9","author":"Chiu","year":"2022","journal-title":"Can J Kidney Health Dis"},{"key":"10.1053\/j.jrn.2025.07.004_bib44","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1681\/ASN.0000000512","article-title":"ASN Kidney Health Guidance Workgroup on Obesity and Kidney Diseases: ASN kidney health guidance on the management of obesity in persons living with kidney diseases","volume":"35","author":"Ikizler","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib46","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/oby.23599","article-title":"Obstacles and opportunities in managing coexisting obesity and CKD: report of a scientific workshop cosponsored by the National Kidney Foundation and the Obesity Society","volume":"30","author":"Friedman","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2025.07.004_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diab Endocrin"},{"key":"10.1053\/j.jrn.2025.07.004_bib48","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Global","year":"2013","journal-title":"Kidney Inter Suppl"},{"key":"10.1053\/j.jrn.2025.07.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100814","article-title":"The 10-year effects of intensive lifestyle intervention on kidney outcomes","volume":"6","author":"Lavenburg","year":"2024","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004079","article-title":"Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial","volume":"12","author":"Knowler","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1053\/j.jrn.2025.07.004_bib50","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"key":"10.1053\/j.jrn.2025.07.004_bib51","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib53","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000000750","article-title":"GLP-1 receptor agonist outcomes, safety, and BMI change in a national cohort of dialysis patients","author":"Orandi","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41591-024-03327-6","article-title":"Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial","volume":"31","author":"Apperloo","year":"2024","journal-title":"Nat Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib55","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.14443","article-title":"Potential kidney protection with liraglutide and semaglutide: exploratory mediation analysis","volume":"23","author":"Mann","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1053\/j.jrn.2025.07.004_bib56","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","article-title":"Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes","volume":"91","author":"Clase","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib58","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1681\/ASN.2018010103","article-title":"Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG outcome trial","volume":"29","author":"Wanner","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib59","series-title":"KI Reports","article-title":"Finerenone and estimated GFR slope in type 2 diabetes and CKD","author":"Yamanouchi","year":"2025"},{"key":"10.1053\/j.jrn.2025.07.004_bib60","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000764","article-title":"Kidney Parameters with tirzepatide in obesity with or without type 2 diabetes","author":"Heerspink","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib61","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41591-024-03133-0","article-title":"Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial","volume":"30","author":"Mann","year":"2024","journal-title":"Nat Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.124.071689","article-title":"Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis","volume":"150","author":"Neuen","year":"2024","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2025.07.004_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae250","article-title":"Semaglutide-associated kidney injury","volume":"17","author":"Begum","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.jrn.2025.07.004_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s13668-025-00649-w","article-title":"Impact of GLP- 1 receptor agonist therapy in patients high risk for sarcopenia","volume":"14","author":"Memel","year":"2025","journal-title":"Curr Nutr Rep"},{"key":"10.1053\/j.jrn.2025.07.004_bib65","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-025-09967-4","article-title":"New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?","author":"Ryan","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1053\/j.jrn.2025.07.004_bib67","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2023.11.032","article-title":"Randomized trial of effect of bariatric surgery on blood pressure after 5 Years","volume":"83","author":"Schiavon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2025.07.004_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0420","article-title":"Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity","volume":"155","author":"Cohen","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib70","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14340","article-title":"Ten-year outcomes following Roux-en-Y gastric bypass vs duodenal switch for high body mass index: a randomized clinical trial","volume":"7","author":"Salte","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jrn.2025.07.004_bib71","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib72","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.2017060707","article-title":"Effect of bariatric surgery on CKD risk","volume":"29","author":"Friedman","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib73","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2337\/dc19-1703","article-title":"Renal and cardiovascular outcomes after weight loss from gastric bypass surgery in type 2 diabetes: Cardiorenal risk reductions exceed Atherosclerotic benefits","volume":"43","author":"Liakopoulos","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2025.07.004_bib74","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/M17-2383","article-title":"Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study","volume":"169","author":"O'Brien","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib75","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41366-018-0045-x","article-title":"Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study","volume":"42","author":"Shulman","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.jrn.2025.07.004_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6820","article-title":"Association between bariatric surgery and major adverse diabetes outcomes in patients with diabetes and obesity","volume":"4","author":"Doumouras","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jrn.2025.07.004_bib77","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.soard.2023.02.024","article-title":"Benefits of bariatric surgery on microvascular outcomes in adult patients with type 2 diabetes: a systematic review and meta-analysis","volume":"19","author":"Obeso-Fernandez","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.jrn.2025.07.004_bib78","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1097\/SLA.0000000000004851","article-title":"Bariatric surgery and risk of death in persons with chronic kidney disease","volume":"276","author":"Coleman","year":"2021","journal-title":"Ann Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamasurg.2020.0829","article-title":"Bariatric surgery and long-term survival in patients with obesity and end-stage kidney disease","volume":"155","author":"Sheetz","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib80","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.jrn.2022.03.003","article-title":"State-of-the-art medical therapy versus Roux-en-Y gastric bypass alone for treatment of early diabetic kidney disease","volume":"32","author":"Friedman","year":"2022","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2025.07.004_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/SLA.0000000000006379","article-title":"Renoprotective effects of metabolic surgery versus GLP1 receptor agonists on progression of kidney impairment in patients with established kidney disease","volume":"280","author":"Aminian","year":"2024","journal-title":"Ann Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib82","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11695-018-3604-2","article-title":"National postoperative bariatric surgery outcomes in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Cohen","year":"2018","journal-title":"Obes Surg"},{"key":"10.1053\/j.jrn.2025.07.004_bib83","doi-asserted-by":"crossref","first-page":"236","DOI":"10.34067\/KID.0004832020","article-title":"The impact of CKD on perioperative risk and mortality after bariatric surgery","volume":"2","author":"Carvalho Silveira","year":"2021","journal-title":"Kidney360"},{"key":"10.1053\/j.jrn.2025.07.004_bib84","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.ki.5002194","article-title":"Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery","volume":"72","author":"Sinha","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2025.07.004_bib85","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.2020101472","article-title":"Management of obesity in adults with CKD","volume":"32","author":"Friedman","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2025.07.004_bib86","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2025.06.015","article-title":"Metabolic bariatric surgery in kidney transplant Candidates","author":"Kukla","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2025.07.004_bib87","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib88","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diab Endo"},{"key":"10.1053\/j.jrn.2025.07.004_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"395","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2025.07.004_bib90","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/dc19-1065","article-title":"Microvascular and cardiovascular outcomes According to renal function in patients treated with Once-weekly Exenatide: Insights from the EXSCEL trial","volume":"43","author":"Bethel","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2025.07.004_bib91","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(22)00243-1","article-title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","volume":"10","author":"Heerspink","year":"2022","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1053\/j.jrn.2025.07.004_bib92","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1111\/dom.15860","article-title":"Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: a post hoc analysis of the SUSTAIN 6 randomized controlled trial","volume":"26","author":"Wang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1053\/j.jrn.2025.07.004_bib93","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfae150","article-title":"Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6","volume":"40","author":"Apperloo","year":"2025","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2025.07.004_bib94","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib95","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa2411528","article-title":"Once-weekly Mazdutide in Chinese adults with obesity or overweight","volume":"392","author":"Ji","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2025.07.004_bib96","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/dc24-1773","article-title":"Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1-5 clinical trials","volume":"48","author":"Apperloo","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2025.07.004_bib97","first-page":"1980","article-title":"The effect of Retatrutide on kidney Parameters in participants with type 2 diabetes Mellitus and\/or obesity","volume":"10","author":"Heerspink","year":"2025","journal-title":"KI Rep"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227625001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227625001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:19:51Z","timestamp":1758590391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227625001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1051227625001396"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2025.07.004","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Management of Obesity in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2025.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}